Transvaginal phosphodiesterase inhibitors for infertility treatment
AssigneeProkrea Bcn, S.L.
InventorsMaria Carmen Pardina Palleja, Miguel Angel Vaz-Romero Uña
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors.
Claims30
A phosphodiesterase inhibitor for use in the treatment of couples with infertility administered transvaginally.
A pharmaceutical composition in the form of hydrophilic gel for transvaginal administration comprising a phosphodiesterase inhibitor, a polyhydroxy alcohol, water, a carbomer and an alkaline agent.
Dependencies are inferred from the claim text.